The store will not work correctly when cookies are disabled.
4-((1H-Imidazol-1-yl)methyl)-7-ethyl-2-phenyl-7H-pyrrolo-[2,3-h]quinoline
ID: ALA2442758
PubChem CID: 72703685
Max Phase: Preclinical
Molecular Formula: C23H20N4
Molecular Weight: 352.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCn1ccc2c3nc(-c4ccccc4)cc(Cn4ccnc4)c3ccc21
Standard InChI: InChI=1S/C23H20N4/c1-2-27-12-10-20-22(27)9-8-19-18(15-26-13-11-24-16-26)14-21(25-23(19)20)17-6-4-3-5-7-17/h3-14,16H,2,15H2,1H3
Standard InChI Key: JJBBGSQNJYBGBL-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 31 0 0 0 0 0 0 0 0999 V2000
14.5873 -4.7350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3062 -5.1479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0155 -3.9083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0162 -4.7350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7273 -5.1460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4464 -4.7354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4458 -3.9097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7300 -3.4984 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.5884 -3.9120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3024 -3.4985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1297 -2.6875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3131 -2.6066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9704 -3.3524 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.1619 -3.4971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7290 -5.9709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4443 -6.3818 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.5359 -7.2010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3432 -7.3708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7541 -6.6555 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.2009 -6.0438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8745 -3.9144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5900 -3.5024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5912 -2.6751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8707 -2.2615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1582 -2.6758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1624 -3.5181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6149 -2.9010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9 1 2 0
1 2 1 0
2 4 2 0
3 10 2 0
3 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 3 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 9 1 0
7 14 1 0
5 15 1 0
15 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 16 1 0
14 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 14 1 0
13 26 1 0
26 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 352.44 | Molecular Weight (Monoisotopic): 352.1688 | AlogP: 5.12 | #Rotatable Bonds: 4 |
Polar Surface Area: 35.64 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 6.46 | CX LogP: 4.67 | CX LogD: 4.64 |
Aromatic Rings: 5 | Heavy Atoms: 27 | QED Weighted: 0.45 | Np Likeness Score: -1.36 |
References
1. Ferlin MG, Carta D, Bortolozzi R, Ghodsi R, Chimento A, Pezzi V, Moro S, Hanke N, Hartmann RW, Basso G, Viola G.. (2013) Design, synthesis, and structure-activity relationships of azolylmethylpyrroloquinolines as nonsteroidal aromatase inhibitors., 56 (19): [PMID:24025069] [10.1021/jm400377z] |